XML 65 R46.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders’ Equity (Tables)
12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Schedule of Share-based Payment Arrangement, Option, Activity
The following table summarizes option activity under the plans:
Options OutstandingWeighted-Average RemainingAggregate Intrinsic Value
(In Millions)
Number of SharesWeighted Average Exercise PriceContract Term
(In Years)
Outstanding as of January 1, 20221,901,163$33.05 8.3$84.8 
Granted625,57845.07 — 
Exercised(145,525)13.80 3.7 
Cancelled/Expired(394,328)41.61 2.2 
Outstanding as of December 31, 20221,986,978$36.54 7.8$1.3 
Granted— 
Exercised(103,047)11.89 0.5 
Cancelled/Expired(294,402)24.07 0.2 
Outstanding as of December 31, 20231,589,529$16.13 6.8$0.2 
Vested and exercisable as of December 31, 20231,386,891$16.16 6.7$0.2 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The fair value of granted stock options was estimated as of the date of grant using the Black-Scholes-Merton option-pricing model, based on the following inputs:
December 31,
2022
Expected term (in years)
5.0 - 6.7
Expected volatility
29.6% - 30.9%
Risk-free interest rate
2.7% - 3.0%
Expected dividend yield— %
Schedule of Share-based Payment Award, Restricted Stock Units and Performance Restricted Stock Units, Valuation Assumptions
The following table presents the assumptions utilized in the Monte Carlo valuation model for market-based awards for the period indicated:
December 31,
2022
Expected term (in years)4.1
Expected volatility95.0 %
Risk-free interest rate2.9 %
Expected dividend yield— %
Schedule of Unvested Restricted Stock Units Roll Forward
The following table summarizes the RSU and PRSU activity years ended December 31, 2023 and 2022:
Number of SharesWeighted Average Grant-Date Fair Value per Share
Unvested and outstanding as of December 31, 20211,165,571$99.85 
Granted2,829,77430.49 
Vested(444,105)87.10 
Canceled and forfeited(669,256)67.89 
Unvested and outstanding as of December 31, 20222,881,984$41.15 
Granted1,579,87116.89 
Vested(1,139,308)39.41 
Canceled and forfeited(787,864)36.26 
Unvested and outstanding as of December 31, 20232,534,683 $28.28 
Schedule of Share-based Payment Arrangement, Expensed and Capitalized, Amount
Total stock-based compensation expense, classified in the accompanying consolidated statements of operations and comprehensive loss was as follows (in millions):
Year Ended
December 31,
20232022
Losses and loss adjustment expenses$1.2 $2.6 
Insurance related expenses4.9 5.4 
Technology and development12.5 19.2 
Sales and marketing13.1 13.7 
General and administrative25.8 21.0 
Total stock-based compensation expense$57.5 $61.9